Genmab A/S
Recent News About Genmab A/S
-
Seagen, Genmab announce Phase 2 results of squamous cell carcinoma monotheraphy trial
Phase 2 results of a squamous cell carcinoma of the head and neck monotherapy clinical trail were recently presented by pharmaceutical companies Seagen and Genmab.